Clinical trial
COMBINE (Acamprosate/Naltrexone)
NCT00006206 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00006206 |
|---|---|
| Title | COMBINE (Acamprosate/Naltrexone) |
| Official title | COMBINE: Effect of Combined Pharmacotherapies and Behavioral Interventions |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH Lipha Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | naltrexone (Revia), acamprosate (Campral) |
| Enrollment | 1,375 |
| Start date | Aug 1, 1997 |
| Completion | May 1, 2006 |
| First posted | Sep 12, 2000 |
| Last update posted | May 3, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: